Study: Januvia plays well with metformin

Merck's new diabetes drug Januvia delivered good blood sugar control over two years of treatment in combination with the older drug metformin, according to a new study the company is touting at the European Associaiton for the Study of Diabetes meeting. Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.